chr13-51937383-A-G
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000053.4(ATP7B):c.3914T>C(p.Leu1305Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L1305L) has been classified as Likely benign.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ATP7B | NM_000053.4 | c.3914T>C | p.Leu1305Pro | missense_variant | Exon 19 of 21 | ENST00000242839.10 | NP_000044.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152246Hom.:  0  Cov.: 33 show subpopulations 
GnomAD4 exome  AF:  0.00000342  AC: 5AN: 1461886Hom.:  0  Cov.: 34 AF XY:  0.00000275  AC XY: 2AN XY: 727244 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152246Hom.:  0  Cov.: 33 AF XY:  0.0000134  AC XY: 1AN XY: 74386 show subpopulations 
ClinVar
Submissions by phenotype
Wilson disease    Pathogenic:3Uncertain:1 
- -
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1305 of the ATP7B protein (p.Leu1305Pro). This variant is present in population databases (rs377144951, gnomAD 0.0009%). This missense change has been observed in individual(s) with Wilson disease (PMID: 11180609, 17272994, 19596473, 26819605). ClinVar contains an entry for this variant (Variation ID: 582922). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ATP7B protein function. For these reasons, this variant has been classified as Pathogenic. -
This missense variant replaces leucine with proline at codon 1305 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with Wilson disease in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The p.Leu1305Pro variant in ATP7B has been previously reported in at least 5 individuals with Wilson disease, including 2 of which were compound heterozygous for the pathogenic p.His1069Gln variant and one who was compound heterozygous for p.Ala1135fs; though, it doesn't appear variants were phased (Folhoffer 2007 PMID 17272994; Posada 2017 abstract; Nemeth 2015 PMID 26819605, Genschel 2000 PMID 11180609). This variant was absent from large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive Wilson disease. ACMG/AMP criteria applied: PM2, PM3, PP3, PP4. -
not provided    Pathogenic:2 
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22692182, 11180609, 15967699, 20958917, 35220961, 19596473, 26819605, 35005072, 30466937, 17272994, 33640437) -
ATP7B: PM3:Very Strong, PM2, PP3, PP4 -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at